Evidence supporting the use of: Antioxidant (unspecified)
For the health condition: Chronic Obstructive Pulmonary Disorder

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Antioxidants have been investigated for their potential role in supporting the management of Chronic Obstructive Pulmonary Disease (COPD). The rationale stems from the observation that oxidative stress is a key contributor to the pathogenesis of COPD, as chronic exposure to cigarette smoke and other pollutants leads to increased free radical production and reduced antioxidant defenses in lung tissues. Several antioxidants, such as N-acetylcysteine (NAC), vitamin C, and vitamin E, have been studied for their ability to modulate oxidative stress and inflammation in COPD patients.

Clinical studies, particularly with N-acetylcysteine, have shown modest benefits in reducing exacerbation frequency and improving some clinical outcomes, though the evidence is not uniformly strong. Meta-analyses and guidelines such as GOLD (Global Initiative for Chronic Obstructive Lung Disease) acknowledge that certain antioxidants may provide benefit in specific patient populations, but they are not considered first-line therapies. Overall, while there is scientific rationale and some supporting evidence for the use of antioxidants in COPD, the overall strength and consistency of the evidence are moderate at best, and more research is needed to define clear clinical recommendations. The evidence rating of 2 reflects limited but suggestive support, based on available clinical trials and systematic reviews.

More about Antioxidant (unspecified)
More about Chronic Obstructive Pulmonary Disorder

Products containing Antioxidant (unspecified)

We currently have no products on Vitabase that contain this ingredient.